v3.25.2
Consolidated Balance Sheets
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
CURRENT ASSETS    
Cash and Cash Equivalents $ 2,629,287 $ 4,738,504
Restricted Cash 29,013 129,778
Accounts Receivable, Net 1,277,635 281,049
Deferred Cost of Goods 507,308  
Inventory, Net 148,120 324,515
Other Current Assets 435,052 435,581
Total Current Assets 5,026,415 5,909,427
PROPERTY AND EQUIPMENT, NET 68,677 98,575
Other Assets 84,424 298,163
Total Assets 5,179,516 6,306,165
CURRENT LIABILITIES    
Accounts and Other Payables 1,748,857 1,308,914
Short Term Debt 427,025 348,771
Current Portion of Long-Term Debt 122,007
Total Current Liabilities 2,297,889 1,657,685
LONG-TERM DEBT 376,188
STOCKHOLDERS’ EQUITY    
Common Stock, $0.00001 par value; 300,000,000 shares authorized; 2,808,071 and 2,021,236 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively 28 20
Additional Paid-In Capital 55,962,337 54,065,775
Accumulated Comprehensive Loss (280,209) (221,418)
Accumulated Deficit (53,176,717) (49,195,897)
Total Stockholders’ Equity 2,505,439 4,648,480
Total Liabilities and Stockholders’ Equity 5,179,516 6,306,165
Series B Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY    
Series B Preferred Stock, $0.00001 par value; 500 shares authorized, no shares issued and outstanding as of December 31, 2024 and December 31, 2023.